CHENGDU GUIBAO SCIENCE & TECHNOLOGY CO.,LTD. Financials Chengdu Guibao Science & Technology Co.,Ltd.
Equities
300019
CNE100000GN5
Specialty Chemicals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.58 CNY | -2.65% |
|
+3.66% | -17.75% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,313 | 5,713 | 7,876 | 6,141 | 6,449 | 5,311 | - | - |
| Enterprise Value (EV) 1 | 3,313 | 5,713 | 7,876 | 6,141 | 6,449 | 5,311 | 5,311 | 5,311 |
| P/E ratio | 25.5 x | 28.4 x | 28.7 x | 24.6 x | 20.5 x | 13.9 x | 11.1 x | 7.91 x |
| Yield | - | - | 1.49% | 1.91% | 1.82% | 2.21% | 3.07% | 3.61% |
| Capitalization / Revenue | - | 3.75 x | 3.08 x | 2.28 x | 2.47 x | 1.59 x | 1.23 x | 1.04 x |
| EV / Revenue | - | 3.75 x | 3.08 x | 2.28 x | 2.47 x | 1.59 x | 1.23 x | 1.04 x |
| EV / EBITDA | - | 20.9 x | 22.3 x | 18.4 x | 15.4 x | 10.6 x | 8.77 x | 6.24 x |
| EV / FCF | - | - | 89.2 x | - | 26 x | -57.1 x | 23.4 x | 17.1 x |
| FCF Yield | - | - | 1.12% | - | 3.84% | -1.75% | 4.27% | 5.84% |
| Price to Book | - | 5.45 x | 3.69 x | 2.76 x | 2.65 x | 2.02 x | 1.76 x | 1.56 x |
| Nbr of stocks (in thousands) | 327,342 | 330,402 | 390,660 | 390,620 | 390,595 | 391,065 | - | - |
| Reference price 2 | 10.12 | 17.29 | 20.16 | 15.72 | 16.51 | 13.58 | 13.58 | 13.58 |
| Announcement Date | 3/30/20 | 3/26/21 | 3/25/22 | 2/10/23 | 2/2/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,524 | 2,556 | 2,694 | 2,606 | 3,346 | 4,316 | 5,127 |
| EBITDA 1 | - | 273.4 | 352.7 | 333 | 418.4 | 503.3 | 605.2 | 851 |
| EBIT 1 | - | 230.2 | 302.9 | 277.1 | 357 | 435.2 | 541.8 | 752.7 |
| Operating Margin | - | 15.11% | 11.85% | 10.28% | 13.7% | 13.01% | 12.56% | 14.68% |
| Earnings before Tax (EBT) 1 | - | 229.8 | 299.3 | 276.3 | 355.4 | 434.4 | 541.2 | 752 |
| Net income 1 | 131.6 | 201.3 | 267.7 | 250.3 | 315.2 | 383.8 | 480 | 671.7 |
| Net margin | - | 13.21% | 10.47% | 9.29% | 12.1% | 11.47% | 11.12% | 13.1% |
| EPS 2 | 0.3976 | 0.6082 | 0.7024 | 0.6400 | 0.8059 | 0.9780 | 1.227 | 1.717 |
| Free Cash Flow 1 | - | - | 88.25 | - | 247.7 | -93 | 227 | 310 |
| FCF margin | - | - | 3.45% | - | 9.51% | -2.78% | 5.26% | 6.05% |
| FCF Conversion (EBITDA) | - | - | 25.02% | - | 59.21% | - | 37.51% | 36.43% |
| FCF Conversion (Net income) | - | - | 32.97% | - | 78.59% | - | 47.29% | 46.15% |
| Dividend per Share 2 | - | - | 0.3000 | 0.3000 | 0.3000 | 0.3000 | 0.4175 | 0.4900 |
| Announcement Date | 3/30/20 | 3/26/21 | 3/25/22 | 2/10/23 | 2/2/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 637.6 | 675.4 | 530.7 | - | 693.2 | 474.5 | 743 | 890 | 849 | 610 | 892 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - |
| Net income | 102.8 | - | - | - | 91.24 | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS | 0.2628 | - | - | - | 0.2333 | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/19/22 | 10/24/22 | 2/10/23 | 4/21/23 | 10/18/23 | 2/2/24 | 4/19/24 | - | - | - | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | 88.3 | - | 248 | -93 | 227 | 310 |
| ROE (net income / shareholders' equity) | - | 20.9% | 14.7% | 11.8% | 13.7% | 12.2% | 15.2% | 18.3% |
| ROA (Net income/ Total Assets) | - | - | - | 8.64% | - | 9.2% | 10.6% | 12.8% |
| Assets 1 | - | - | - | 2,897 | - | 4,172 | 4,542 | 5,268 |
| Book Value Per Share 2 | - | 3.170 | 5.460 | 5.690 | 6.240 | 6.720 | 7.730 | 8.710 |
| Cash Flow per Share 2 | - | 0.6700 | 0.4600 | 0.3200 | 1.110 | 0.6300 | 1.540 | 1.980 |
| Capex 1 | - | - | 87.3 | 107 | 188 | 189 | 154 | 129 |
| Capex / Sales | - | - | 3.42% | 3.98% | 7.22% | 5.63% | 3.57% | 2.51% |
| Announcement Date | 3/30/20 | 3/26/21 | 3/25/22 | 2/10/23 | 2/2/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
13.58
CNY
Average target price
18.2
CNY
Spread / Average Target
+34.02%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -17.75% | 754M | |
| +15.67% | 35.85B | |
| +0.52% | 4.47B | |
| +35.41% | 1.47B | |
| -2.41% | 1.36B | |
| -24.75% | 779M | |
| -22.45% | 767M | |
| -40.33% | 631M | |
| -21.66% | 601M | |
| -14.95% | 440M |
- Stock Market
- Equities
- 300019 Stock
- Financials Chengdu Guibao Science & Technology Co.,Ltd.